Related references
Note: Only part of the references are listed.Ticagrelor improves blood viscosity-dependent microcirculatory flow in patients with lower extremity arterial disease: the Hema-kinesis clinical trial
Robert S. Rosenson et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Ticagrelor and the Prevention of Microvascular Complications in Diabetes Patients with Lower Extremity Arterial Disease; Rationale and Design of the Hema-Kinesis Trial
Robert S. Rosenson et al.
CARDIOVASCULAR DRUGS AND THERAPY (2018)
Residual microvascular risk in diabetes: unmet needs and future directions
Paola Fioretto et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
A Keech et al.
LANCET (2005)
Share Paper
